Disease-A-Month
Volume 55, Issue 2 , Pages 45-113 , February 2009

Menstrual Disorders in Adolescent Females: Current Concepts

References 

  1. Greydanus DE. Breast and gynecologic disorders. In:  Hofmann AD,  Greydanus DE editor. Adolescent Medicine. 3rd ed.. Stamford, CT: Appleton & Lange; 1997;p. 520–565Ch. 25
  2. Greydanus DE, Omar H, Tsitsika A, et al. Menstrual disorders in adolescents. In:  Omar H,  Greydanus DE,  Tsitsika A editor. Pediatric and Adolescent Sexuality and Gynecology. Merrick. NY: Novi Science Publishers; 2009;p. 175–260Ch. 8
  3. Draznin MD. Endocrinology. In:  Greydanus DE,  Patel DR,  Pratt HD editor. Essential Adolescent Medicine. NY: McGraw-Hill Medical Publishers; 2006;p. 234–250Ch 13
  4. Kaplowitz PB. Puberty, normal, and menarche. In:  Hillard PJA editors. The 5-Minute Obstetrics and Gynecology Consult. Philadelphia, PA: Wolters Kluwer/Lippincott Williams & Wilkins; 2008;p. 8–39
  5. Kaplowitz PB. Pubertal development in girls: secular trends. Curr Opin Obstet Gynecol. 2006;18:487–491
  6. Greenfield TP, Blythe MJ. Menstrual disorders in adolescents. In:  Greydanus DE,  Patel DR,  Pratt HD editor. Essential Adolescent Medicine. New York, NY: McGraw-Hill Medical Publishers; 2006;p. 591–612Ch. 28
  7. Strickland JL, Wall JW. Abnormal uterine bleeding in adolescents. Obstet Gynecol Clin North Am. 2003;30:321–335
  8. Knobil E. The neuroendocrine control of the menstrual cycle. Recent Prog Horm Res. 1980;36:53–58
  9. Greydanus DE, Tsitsika A, Gains M. The gynecology system and the adolescent. In:  Greydanus DE,  Feinberg AN,  Patel DR, et al. editor. The Pediatric Diagnostic Examination. New York, NY: McGraw-Hill Medical Publishers; 2007;p. 701–749Ch. 22
  10. Hillier SG, Eichert E, VanHall EV. Control of preovulatory follicular estrogen biosynthesis in the human ovary. J Clin Endocrinol Metab. 1981;52(5):847–856
  11. Lockwood GM, Muttukrishna S, Ledger WL. Inhibins and activins in human ovulation, conception and pregnancy. Hum Rep Update. 1998;4(3):284–295
  12. Filicori M, Santoro N, Merriam G. Characterization of the physiological pattern of episodic gonadotropin secretion throughout the human menstrual cycle. J Clin Endocrinol Metab. 1986;62(6):1136
  13. Tibibzadeh S, Satyaswaroop PG. Sex steroid receptors in lymphoid cells of human endometrium. Am J Clin Pathol. 1998;91:656–663
  14. Salamonsen LA, Woolley DE. Menstruation: induction by matrix metalloproteinases and inflammatory cells. J Reprod Immunol. 1999;44:1–27
  15. Salamonsen LA, Butt AR, Hammond FR. Induction of endometrial matrix metalloproteinases, but not their tissue inhibitors, is modulated by progesterone withdrawal in an in vitro model for menstruation. J. Clin Endocrinol Metab. 1997;82:1409–1415
  16. Hampton AL, Salmonsen LA. Expression of messenger ribonucleic acid encoding matrix metalloproteinases and their tissue inhibitors is related to menstruation. In: 1994;p. R1–R3141
  17. Finn CA. Implantation, menstruation and inflammation. Biol Rev. 1986;61:313–328
  18. Sharkey A, Day K, McPherson A, et al. Vascular endothelial growth factor expression in human endometrium is regulated by hypoxia. J Clin Endocrinol Metab. 2000;85:402–409
  19. Smith SK. Angiogenesis, vascular endothelial growth factor and the endometrium. Hum Reprod Update. 1998;4:509–519
  20. Weston G, Rogers PAW. Endometrial angiogenesis. Bailliere's Clin Obstet Gynaecol. 2000;14:919–936
  21. Mueller MD, Lebovic DI, Garrett E, et al. Neutrophils infiltrating the endometrium express vascular endothelial growth factor: potential role in endometrial angiogenesis. Fertil Steril. 2000;74:107–112
  22. Bukulmez O. Luteal phase defect: myth or reality. Obstet Gynecol Clin North Am. 2004;31:727–744
  23. Scheib SA, Batzer F. Luteal phase defect. In:  Hillard PJA editors. The 5-Minute Obstetrics and Gynecology Consult. Philadelphia, PA: Wolters Kluwer/Lippincott Williams & Wilkins; 2008;p. 124–125
  24. Hillard PJ. Adolescent and pediatric gynecology: an introduction. Curr Opin Obstet Gynecol. 2006;18:485–486
  25. Deitch HR, Hillard PJ. Menstrual disorders in the college age female. Pediatr Clin North Am. 2005;52:101–125
  26. Pinto SM. Prepubertal menarche: a defined clinical entity. Am J Obstet Gynecol. 2006;195:327–329
  27. Sugar NF. Common gynecologic problems in prepubertal girls. Pediatr Rev. 2006;27:213–223
  28. Friberg B, Orno AK, Lindgren A, et al. Bleeding disorders among young women: a population-based prevalence study. Acta Obstet Gynecol Scand. 2006;85(2):200–206
  29. Chuong CJ, Renner PF. Management of abnormal uterine bleeding. Am J Obstet Gynecol. 1996;175(3):787–792
  30. Hillard PJA. Menstruation on young girls: a clinical perspective. Obstet Gynecol. 2002;99(4):655–662
  31. Fraser IS, Hickey M, Song JY. A comparison of mechanisms underlying disturbances of bleeding caused by spontaneous dysfunctional uterine bleeding or hormonal contraception. Hum Reprod. 1996;11(2):165–178
  32. Chwalisz K, Garfield RE. Role of nitric oxide in implantation and menstruation. Hum Reprod. 2000;15(3):96–111
  33. Wall JW, Strickland JL. Bleeding, abnormal uterine, in adolescents. In:  Hillard PJA editors. The 5-Minute Obstetrics and Gynecology Consult. Philadelphia, PA: Wolters Kluwer/Lippincott Williams & Wilkins; 2008;p. 4–5
  34. Lukes A. Disorders of hemostasis and escessive menstrual bleeding: prevalence and clinical impact. Fertil Steril. 2005;84:1345–1351
  35. Hord JD. Anemia and coagulation disorders in adolescents. Adolesc Med. 1999;10(3):359–367
  36. Kulkarni R, Gera R, Scott-Emuakpor AB. Adolescent hematology. In:  Greydanus DE,  Patel DR,  Pratt HD, et al. editor. Essential Adolescent Medicine. New York, NY: McGraw-Hill Medical Publishers; 2006;p. 111–145Ch. 17
  37. Bennett K, Daley ML, Pike C. Factor V deficiency and menstruation: a gynecologic challenge. Obstet Gynecol. 1997;89(5 Pt. 2):839–840
  38. Munro MG, Cunningham ES. Bleeding, abnormal uterine: heavy menstrual bleeding. In:  Hillard PJA editors. The 5-Minute Obstetrics and Gynecology Consult. Philadelphia, PA: Wolters Kluwer/Lippincott Williams & Wilkins; 2008;p. 6–7
  39. Koudes PA, Phatak PD, Burkart P, et al. Gynaecological and obstetrical morbidity in women with type I von Willebrand disease: results of a patient survey. Haemophilia. 2000;6(2):54–60
  40. Koudes P. Hemostasis and menstruation: appropriate investigation for underlying hemostasis in women with excessive menstrual bleeding. Fertil Steril. 2005;84:1338–1344
  41. Claessens EA, Cowell CA. Acute adolescent menorrhagia. Am J Obstet Gynecol. 1981;139:277–282
  42. Kadir RA, Sabin CA, Pollard D, et al. Quality of life during menstruation in patients with inherited bleeding disorders. Haemophilia. 1998;4(6):836–841
  43. Falcone T, Desjardins C, Bourque J, et al. Dysfunctional uterine bleeding in the adolescent. Reprod Med. 1994;39:761–764
  44. Kirtava A, Drews C, Lally C, et al. Medical, reproductive and psychosocial experiences of women diagnosed with von Willebrand's disease receiving care in haemophilia treatment centres: a case-control study. Hemophilia. 2003;9(3):292–297
  45. Kadir RA, Economides DL, Sabin CA, et al. Assessment of menstrual blood loss and gynaecological problems in patients with inherited bleeding disorders. Haemophilia. 1999;5(1):40–48
  46. Kadir RA, Sabin CA, Pollard D, et al. Quality of life during menstruation in patients with inherited bleeding disorders. Haemophilia. 1998;4(6):836–841
  47. Quint EH, Smith YR. Abnormal uterine bleeding in adolescents. J Midwifery Womens Health. 2003;48(3):186–191
  48. Collett TF. Irregular uterine bleeding in adolescents. J Pediatr Health Care. 2002;16(6):313;321-2
  49. Livingstone M, Fraser JS. Mechanism of abnormal uterine bleeding. Hum Reprod Update. 2002;8(1):60–67
  50. Lavin C. Dysfunctional uterine bleeding in adolescents. Curr Opin Pediatr. 1996;8(4):328–332
  51. Southam AL, Richart RM. The prognosis for adolescents with menstrual abnormalities. Am J Obstet Gynecol. 1966;94(5):637–645
  52. Greydanus DE, Rimsza ME, Matytsina L. Contraception for college students. Pediatr Clin No Amer. 2005;52:135–161
  53. Hickey M. Progestogens versus oestrogens and progestogens for irregular bleeding associated with anovulation. Cochrane Database Sys Rev. 2007;1:(CD002126)
  54. Cunningham S, Munro MB. Bleeding, abnormal uterine: irregular and intermenstrual. In:  Hillard PJA editors. The 5-Minute Obstetrics and Gynecology Consult. Philadelphia, PA: Wolters Kluwer/Lippincott Williams & Wilkins; 2008;p. 10–11
  55. Apgar BS, Kaufman D, Uche GN, et al. Treatment of menorrhagia. Am Fam Phys. 2007;75:1813–1819
  56. Greydanus DE. Contraception in chronically ill adolescents. Internation J Disabil Hum Develop. 2009;2007:1
  57. Best KA, Kaunitz AM. Bleeding, abnormal uterine: with hormonal therapy or contraception. In:  Hillard PJA editors. The 5-Minute Obstetrics and Gynecology Consult. Philadelphia, PA: Wolters Kluwer/Lippincott Williams & Wilkins; 2008;p. 8–9
  58. Bevan JA, Maloney KW, Hillery CA, et al. Bleeding disorders: a common cause of menorrhagia in adolescents. J Pediatr. 2001;138(6):856–861
  59. Greydanus DE, Paul K, Patel DR. Menstrual bleeding and the adolescent. Italian J Adol Med. 2008;
  60. Matytsina LA, Zoloto EV, Sinenko LV, et al. Dysfunctional uterine bleeding in adolescents: concepts of pathophysiology and management. Prim Care: Clin Office Pract. 2006;33(2):503–515
  61. Rizk DE, Kumar RM. Congenital afibrinogenemia: treatment of excessive menstrual bleeding with continuous oral contraceptive. Am J Hematol. 1996;52(3):237–238
  62. Greydanus DE, Tsitsika A, Matytsina L. Contraception. In:  Omar H,  Greydanus DE,  Tsitsika A editor. Pediatric and Adolescent Sexuality and Gynecology. Merrick, NY: Novi Science Publishers; 2009;p. 300–350Ch. 9
  63. A progestin-releasing IUD for long-term contraception. Med Lett. 2001;67:7–8
  64. Phillips V, Graham CT, Manek S, et al. The effects of levonorgestrel intrauterine system (Mirena coil) on endometrial morphology. J Clin Pathol. 2003;56:305–307
  65. Majorbanks J. Surgery versus medical therapy for heavy menstrual bleeding. Cochrane Database Sys Rev. 2006;2:(CD005326)
  66. Iglesias EA, Coupey SM. Menstrual cycle abnormalities: diagnosis and management (State of the Art Reviews). Adolesc Med. 1999;10(2):255–273
  67. Joffe A, Blythe MJ. Handbook of adolescent medicine. Adolesc Med. 2003;14:289–307
  68. Polaneczky MM, Slap GB. Menstrual disorders in the adolescent: amenorrhea. Pediatr Rev. 1992;13:43–46
  69. The Practice Committee of the American Society for Reproductive Medicine (Current evaluation of amenorrhea). Fertil Steril. 2006;86(suppl 4):S148–S155
  70. Welt CK. Etiology, diagnosis, and treatment of primary amenorrhea. UptoDate Online. 2005;14:3
  71. Sybert VP. Turner syndrome. N Engl J Med. 2004;351:1227–1238
  72. Posner JC. Early detection of imperforate hymen prevents morbidity from delays in diagnosis. Pediatrics. 2005;115:1008–1012
  73. Liang CC. Long-term follow-up of women who underwent surgical correction of imperforate hymen. Arch Obstet Gynecol. 2003;269:5–8
  74. Welt CK. Etiology, diagnosis, and treatment of secondary amenorrhea. UptoDate Online. 2005;14:3
  75. Mitan LAP. Diet, eating disorder: anorexia nervosa. In:  Hillard PJA editors. The 5-Minute Obstetrics and Gynecology Consult. Philadelphia, PA: Wolters Kluwer/Lippincott Williams & Wilkins; 2008;p. 268–269
  76. Reddy V. Eating disorders. In:  Omar H,  Greydanus DE,  Tsitsika A editor. Pediatric and Adolescent Sexuality and Gynecology. Merrick, NY: Novi Science Publishers; 2009;p. 340–361Ch. 15
  77. Mitan LAP. Menstrual dysfunction in anorexia nervova. J Pediatr Adolesc Gynecol. 2004;17:81–85
  78. Pratt HD, Tsitsika AK. Fetal, childhood, and adolescence interventions leading to adult disease prevention. Primary Care Clin Office Pract. 2007;34:203–217
  79. Witchel SF. Hyperandrogenism in adolescents. Adolesc Med. 2002;13:89–99
  80. Bondy CA. Turner Syndrome Study Group: care of girls and women with Turner Syndrome: a guideline of the Turner Syndrome Study Group. J Clin Endocrinol Metab. 2007;92:10–25
  81. Lee PA, Houk CP. Gonadal dysgenesis. In:  Hillard PJA editors. The 5-Minute Obstetrics and Gynecology Consult. Philadelphia, PA: Wolters Kluwer/Lippincott Williams & Wilkins; 2008;p. 112–113
  82. Backeljauw PF. Turner syndrome. In:  Hillard PJA editors. The 5-Minute Obstetrics and Gynecology Consult. Philadelphia, PA: Wolters Kluwer/Lippincott Williams & Wilkins; 2008;p. 186–187
  83. Salmi DJ, Zisser HC, Jovanovic L. Screening for and treatment of polycystic ovary syndrome in teenagers. Exp Biol Med. 2004;229:369–377
  84. Azziz R. PCOS: a diagnostic challenge. Reprod Biomed Online. 2004;8:644–648
  85. Orio F, Vuolo L, Palomba S, et al. Metabolic and cardiovascular consequences of polycystic ovary syndrome. Minerva Ginecol. 2008;60:39–51
  86. Miller RJ. Bleeding, abnormal uterine: oligomenorrhea. In:  Hillard PJA editors. The 5-Minute Obstetrics and Gynecology Consult. Kluwer/Lippincott: Williams & Wilkins; 2008;p. 12–13
  87. Paradise J. Evaluation of oligomenorrhea in adolescence. UptoDate Online. 2006;14:3–6
  88. Legro RS, Castracane VD, Kauffman RP. Detecting insulin resistance in polycystic ovary syndrome: purposes and pitfalls. Obstet Gynecol Surv. 2004;59:141–154
  89. Ferriman D. Clinical assessment of body hair growth in women. J Clin Endocrinol. 1961;21:1440–1447
  90. Wild RA. Ferriman Gallwey self-scoring: performance assessment in women with polycystic ovary syndrome. J Clin Endocrinol Metabol. 2005;90:4112–4114
  91. Rager KM. Acanthosis nigricans. In:  Hillard PJA editors. The 5-Minute Obstetrics and Gynecology Consult. Philadelphia, PA: Wolters Kluwer/Lippincott Williams & Wilkins; 2008;p. 62–63
  92. The Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop (Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)). Hum Reprod. 2004;19:41–47
  93. Azziz R. Diagnosis of polycystic ovarian syndrome: the Rotterdam criteria are premature. J Clin Endocrinol Metabol. 2006;91(3):781–785
  94. Omar HA. Clinical profiles, occurrence, and management of adolescent patients with HAIR-AN syndrome. Sci World J. 2004;4:507–511
  95. Aubuchon M. Polycystic ovarian syndrome (PCOS). In:  Hillard PJA editors. The 5-Minute Obstetrics and Gynecology Consult. Philadelphia, PA: Wolters Kluwer/Lippincott Williams & Wilkins; 2008;p. 158–159
  96. Ehrmann DA. Polycystic ovary syndrome. N Engl J Med. 2005;352:1223–1236
  97. Guzick DS. Polycystic ovary syndrome. Obstet Gynecol. 2004;103:181–193
  98. Orchard TJ. The effect of metformin and intensive lifestyle intervention in the metabolic syndrome (The Diabetes Prevention Program randomized trial). Ann Intern Med. 2005;142:611–619
  99. Mastorakos G. Polycystic ovary syndrome in adolescents: current and future treatment options. Paediatr Drugs. 2006;8:311–318
  100. Bricker L, Greydanus DE. The metabolic syndrome: a gathering challenge in a time of abundance (State of the Art Review). A Adoles Med. 2008;19:333–350
  101. Harborne L, Fleming R, Lyall H, et al. Metformin or antiandrogen in the treatment of hirsutism in polycystic ovary syndrome. J Clin Endocrinol Metab. 2003;88:4116–4123
  102. Elter K, Imir G, Durmusoglu F. Clinical, endocrine, and metabolic effects of metformin added to ethinyl estradiol-cyproterone acetate in non-obese women with polycystic ovarian syndrome: a randomized controlled study. Hum Reprod. 2002;17:1729–1737
  103. Farquhar C, Lee O, Toomath R, et al. Spironolactone versus placebo or in combination with steroids for hirsutism and/or acne. Cochrane Database Syst Rev. 2003;4:CD000194
  104. Kanungo S, Omar HA. Hirsutism. In:  Hillard PJA editors. The 5-Minute Obstetrics and Gynecology Consult. Philadelphia, PA: Wolters Kluwer/Lippincott Williams & Wilkins; 2008;p. 24–25
  105. Chen EC, Brzyski RG. Exercise and reproductive dysfunction. Fertil Steril. 1998;71:1–6
  106. Marshall LA. Amenorrhoea. In:  Drinkwater BA editors. Women in Sport. Oxford: Blackwell Scientific; 2000;p. 377–390Ch. 26
  107. Harber VJ. Menstrual cycle changes in athletic women: a review. Int Sports Med J. 2004;5:56–66
  108. Greydanus DE, Patel DR. The female athlete: before and beyond puberty. Pediatric Clin North Am. 2002;49:553–580
  109. Yurko-Griffin L, Harris SS. Female athletes. In:  Sullivan A,  Anderson S editor. American Academy of Orthopedic Surgery and American Academy of Pediatrics. 2000;p. 137–148Ch. 15
  110. Greydanus DE, Patel DR. The female athlete. In:  Patel DR,  Greydanus DE,  Baker R editor. Pediatric Practice: Sports Medicine. New York, NY: McGraw Hill Medical Publishers; 2008;p. 222–256Ch. 10
  111. Patel DR, Greydanus DE. The female athlete. In:  Omar H,  Greydanus DE,  Tsitsika A editor. Pediatric and Adolescent Sexuality and Gynecology. Merrick, NY: Novi Science Publishers; 2009;p. 340–361Ch. 13
  112. Frisch RE, Wyshak G, Vincent L. Delayed menarche and amenorrhea in ballet dancers. N Engl J Med. 1980;303:17
  113. Otis CL, Drinkwater G, Johnson M, et al. ACSM position stand on the female athlete triad. Med Sci Sports Exerc. 1997;29:I–ix
  114. Dueck A, Matt KS, Manore M, et al. Treatment of athletic amenorrhea with a diet and training intervention program. Int J Sport Nutr. 1996;6:24–40
  115. Dusek T. High intensity training and menstrual cycle disorders in athletes. Int Sports Med J. 2004;5:37–44
  116. Manore MM. Nutritional recommendations and athletic menstrual dysfunction. Int Sports Med J. 2004;5:45–55
  117. Griffin LY. The female athlete. In:  DeLee JC,  Drez D,  Miller MD editor. DeLee and Drez's Orthopaedic Sports Medicine (Principles and Practice). Philadelphia, PA: Elsevier/Saunders; 2003;p. 505–520Ch. 13
  118. Gibson J. Osteoporosis. In:  Drinkwater BA editors. Women in Sport. Oxford: Blackwell Scientific; 2000;p. 391–406Ch. 27
  119. Committee on Sports Medicine and FitnessAmerican Academy of Pediatrics. Amenorrhea in adolescent athletes. Pediatrics. 1989;84:394–395
  120. Greydanus DE, Patel DR. Medical aspects of the female athlete at puberty. Int Sports Med J. 2004;5:1–25
  121. Nattiv A, Arendt EA, Hecht SS. The female athlete. In:  Garrett WE,  Kirkendall DT,  Squire DL editor. Principles and Practice of Primary Care Sport Medicine. Philadelphia, PA: Lippincott Williams and Wilkins; 2001;p. 93–113ch. 8
  122. Committee on Sports Medicine & Nutrition and Fitness, American Academy of Pediatrics (Medical concerns in the female athlete). Pediatrics. 2000;106:610–613
  123. Halpert S, Warren MP. Exercise and female adolescents: effects on the reproductive and musculoskeletal systems. Int Sports Med J. 2004;5:78–88
  124. Hillen TIJ, Grbavac SL, Johnston PJ, et al. Primary dysmenorrhea in young western Australian women: prevalence, impact, and knowledge of treatment. J Adolesc Health. 1999;25:40–45
  125. Harel Z, Hillard PJA. Dysmenorrhea. In:  Hillard PJA editors. The 5-Minute Obstetrics and Gynecology Consult. Philadelphia, PA: Wolters Kluwer/Lippincott Williams & Wilkins; 2008;p. 30–31
  126. Workowski KA, Dowda DF, Voight R, et al. Centers for Disease Control and Prevention (2006 Guidelines for treatment of sexually transmitted diseases). MMWR. 2006;55(No. RR-11):1–100
  127. Johnson J. Level of knowledge among adolescent girls regarding effective treatment for dysmenorrhea. J Adolesc Health Care. 1988;9:398
  128. McDonald M, Rapkin A. Premenstrual syndrome (PMS) and premenstrual dysphoric disorder (PMDD). In:  Hillard PJA editors. The 5-Minute Obstetrics and Gynecology Consult. Philadelphia, PA: Wolters Kluwer/Lippincott Williams & Wilkins; 2008;p. 160–161
  129. Winer SA. Premenstrual disorders: prevalence, etiology, and impact. J Repro Med. 2006;51(suppl 4):229–240
  130. American Psychiatric Association. DSM-IV: Diagnostic and Statistical Manual of Mental Disorders. 4th ed.. Washington, DC: American Psychiatric Association; 1994;
  131. American Psychiatric Association. DSM-IV-TR: Diagnostic and Statistical Manual of Mental Disorders. 4th ed–text revision. Washington, DC: American Psychiatric Association; 2000;
  132. Endicott J, Amsterdam J, Eriksson E, et al. Is premenstrual dysphoric disorder a distinct clinical entity?. J Womens Health Gend Based Med. 1999;8:663–679
  133. Blake F, Salkovskis P, Gath D, et al. Cognitive therapy for premenstrual syndrome: a controlled trial. J Psychosom Res. 1998;45:307–318
  134. Budeiri DJ, Li WP, Dornan JC. Clinical trials of treatments of premenstrual syndrome: entry criteria and scales for measuring treatment outcomes. Br J Obstet Gynaecol. 1994;101:689–695
  135. Cohen LS, Miner C, Brown E, et al. Premenstrual daily fluoxetine for prementrual dysphoric disorder: a placebo-controlled clinical trial using computerized diaries. Obstet Gynecol. 2002;100:435–444
  136. Greydanus DE, Calles JL, Patel DR. Pediatric and Adolescent Psychopharmacology: A Practical Manual for Pediatricians. Cambridge, England: Cambridge University Press; 2008;301 pages
  137. Stevinson C, Ernst E. Complementary/alternative therapies for premenstrual syndrome: a systematic review of randomized controlled trials. Am J Obstet Gynecol. 2001;185:227–235
  138. Zurawski JM. Mittelschmerz. In:  Hillard PJA editors. The 5-Minute Obstetrics and Gynecology Consult. Philadelphia, PA: Wolters Kluwer/Lippincott Williams & Wilkins; 2008;p. 128–129
  139. Olive DL. Endometriosis symposium. Obstet Gynecol Clin North Am. 1997;24:285
  140. Laufer MR, Sanfilippo J, Rose G. Adolescent endometriosis: diagnosis and treatment approaches. J Pediatr Adolesc Gynecol. 2003;16:S3
  141. Black AY, Jamieson MA. Adolescent endometriosis. Curr Opin Obstet Gynecol. 2002;6:467–474
  142. Laufer MR, Goitein BA, Bush M, et al. Prevalence of endometriosis in adolescent women with chronic pelvic pain not responding to conventional therapy. J Pediatr Adoelsc Gynecol. 1997;10:199–202
  143. Massie JAM, Lathi RB, Westphal LM. Endometriosis. In:  Hillard PJA editors. The 5-minute Obstetrics and Gynecology Consult. Philadelphia, PA: Wolters Kluwert/Lippincott Williams & Wilkins; 2008;p. 96–97
  144. Sanfilippo JS. Chronic pelvic pain: medical and surgical approach. In:  Sanfilippo JS,  Muran D,  Lee P, et al. editor. Pediatric and Adolescent Gynecology. Philadelphia, PA: WB Saunders; 1994;p. 635
  145. Kontoravdis A, Hassan E, Hassiakos D, et al. Laparoscopic evaluation and management of chronic pelvic pain during adolescence. Clin Exp Obstet Gynecol. 1999;26:76–77
  146. Yamamoto K, Mitsuhashi Y, Takaike T, et al. Tubal endometriosis diagnosed within one month after menarche: a case report. Tohoko J Exp Med. 1997;181:385–387
  147. ACOG Practice Bulletin. 2004;Chronic pelvic pain, #51, March
  148. Latthe P, Mignini L, Gray R, et al. Factors predisposing women to chronic pelvic pain. BMJ. 2006;332:749–755
  149. Beigi RH. Pelvic inflammatory disease: new diagnostic criteria and treatment. Obstet Gynecol Clin North Am. 2003;30:777–793
  150. Stone SC. Pelvic pain in children and adolescents. In:  Carpenter SC,  Rock JA editor. Pediatric and Adolescent Gynecology. New York, NY: Raven Press; 1992;p. 267
  151. Kennedy S. ESHRE (European Society of Human Reproduction and Embryology) guideline for the diagnosis and treatment of endometriosis. Hum Reprod. 2005;20:2698–2704
  152. Amsterdam LL. Anastrozole and oral contraceptives: a novel treatment for endometriosis. Fertil Steril. 2005;84:300
  153. Vercellini P, Fedele L, Arcaini L, et al. Laparoscopy in the diagnosis of chronic pelvic pain in adolescent women. J Repo Med. 1989;34:827
  154. Rapkin AJ, Reading AE. Chronic pelvic pain. Curr Probl Obstet Gynecol Fertil. 1991;14:101
  155. Goldstein DP. Acute and chronic pelvic pain. Pediatr Clin North Am. 1989;90:573

PII: S0011-5029(08)00148-X

doi: 10.1016/j.disamonth.2008.10.004

Disease-A-Month
Volume 55, Issue 2 , Pages 45-113 , February 2009

Article Tools

* Image Usage & Resolution